Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vera Therapeutics, Inc. | Director | Class A Common Stock | 2.79M | $113M | $40.50 | Mar 25, 2024 | By Sofinnova Venture Partners X, L.P. |
Aerovate Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 12.5K | $205K | $16.37 | Jun 5, 2024 | Direct |
RayzeBio, Inc. | Director | Common Stock | 0 | $0 | $62.50 | Feb 26, 2024 | Indirect |
Vera Therapeutics, Inc. | Director | Stock Option (right to buy) | 14K | May 15, 2024 | Direct | ||
RayzeBio, Inc. | Director | Series D Convertible Preferred Stock | 0 | Sep 19, 2023 | By Sofinnova Venture Partners XI, L.P. | ||
RayzeBio, Inc. | Director | Series D Convertible Preferred Stock | 0 | Sep 19, 2023 | By Sofinnova Venture Partners X, L.P. | ||
RayzeBio, Inc. | Director | Stock Option (right to buy) | 0 | Feb 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVTE | Aerovate Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
VERA | Vera Therapeutics, Inc. | Mar 21, 2024 | 6 | -$34.1M | 4 | Mar 25, 2024 | Director |
RYZB | RayzeBio, Inc. | Feb 26, 2024 | 3 | -$151M | 4 | Feb 27, 2024 | Director |
VERA | Vera Therapeutics, Inc. | Jan 30, 2024 | 1 | $5M | 4 | Feb 1, 2024 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jan 2, 2024 | 1 | $47.5K | 4 | Jan 4, 2024 | Director, 10%+ Owner |
RYZB | RayzeBio, Inc. | Nov 17, 2023 | 1 | $0 | 4 | Nov 17, 2023 | Director |
RYZB | RayzeBio, Inc. | Sep 19, 2023 | 6 | $8.5M | 4 | Sep 21, 2023 | Director |
RYZB | RayzeBio, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jan 3, 2023 | 1 | $47.5K | 4 | Jan 5, 2023 | Director, 10%+ Owner |
AVTE | Aerovate Therapeutics, Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director, 10%+ Owner |
AVTE | Aerovate Therapeutics, Inc. | Jan 3, 2022 | 1 | $47.5K | 4 | Jan 5, 2022 | Director, 10%+ Owner |
AVTE | Aerovate Therapeutics, Inc. | Jul 1, 2021 | 4 | $5.03M | 4 | Jul 6, 2021 | Director, 10%+ Owner |
AVTE | Aerovate Therapeutics, Inc. | Jun 29, 2021 | 0 | $0 | 3 | Jun 29, 2021 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 18, 2021 | 3 | $8M | 4 | May 18, 2021 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 13, 2021 | 1 | $0 | 4 | May 17, 2021 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 13, 2021 | 0 | $0 | 3 | May 13, 2021 | Director, 10%+ Owner |
AVTE | Aerovate Therapeutics, Inc. | Feb 1, 2021 | 3 | $17.5M | 4 | Jul 1, 2021 | Director, 10%+ Owner |